THE REGIONAL DISEASE SURVEILLANCE SYSTEMS ENHANCEMENT (REDISSE) IN WEST AFRICA PROJECT IMPLEMENTED BY WEST AFRICAN HEALTH ORGANISATION (WAHO) ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) In West Africa Project Year ended 31 December 2023 CONTENTS PAGE General Information 1-2 Report of the Project Management Team 3 Independent Auditor’s Report on Financial Statements 4-6 Financial Statements: - Statement of Resources and Uses of Funds 7 - Statement of Assets and Liabilities 8 - Notes to the Financial Statements 9 – 13 Independent Auditor’s Report on Designated Account 14-16 Designated Account Statement 17 - Notes to the Designated Account Statement 18 Annexes: Annex 1: Reconciliation of amount received by REDISSE and amount disbursed by World Bank Annex 2: Schedule of Fixed Assets Register West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2023 GENERAL INFORMATION Project Management Team Dr Aissi Melchoir Athanase Joel Codjovi Director General Mr. Akpene Dzikum Ag. Director of Administration and Finance (Contract ended 28 April 2023) Mr. Aruna Fallah Ag. Director of Administration and Finance Mr. Sani Ali Director of Planning, & Health Information Dr Olusegun Moses Adeoye Ag. Project Management Unit Coordinator Dr Malik Coulibaly Project Coordinator, REDISSE Dr Sayi Dona Alain Monitoring and Evaluation Specialist Mr. Harouna Dabre Financial Management Specialist Mr. Maurice Adjovi Procurement Specialist Mr. Sylvanus Azumah Illedi Project Accountant Ms. Tosin Adesina Monitoring & Evaluation Assistant (Contract ended 31 October 2023) Mr. Philip Abugri Translator Revisor (Contract ended 31 July 2023) Independent auditor PricewaterhouseCoopers Chartered Accountants PwC Tower A4 Rangoon Lane, Cantonments City PMB CT 42 Cantonments Accra Registered office West Africa Health Organisation (WAHO) Avenue Ouezzin Coulibaly 01 BP 153, Bobo-Dioulasso Burkina Faso Banker Ecobank SA Ouagadougou, Burkina Faso 1 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2023 GENERAL INFORMATION (CONTINUED) PROJECT BACKGROUND The Regional Disease Surveillance Systems Enhancement Project in West Africa (REDISSE) is a project funded by the World Bank, and the governments of Canada and China, and implemented by the West Africa Health Organisation (WAHO). The project seeks to strengthen national and regional cross-sectoral capacity for collaborative disease surveillance and epidemic preparedness in West Africa. The project seeks to achieve this by addressing the weaknesses in human and animal health systems which impede surveillance and effective response to diseases and in the case of emergencies, provide an effective immediate response. The project which commenced in 2016 has been implemented in phases and is expected to end in August 2023. However, per Negotiations between ECOWAS and IDA regarding the additional financing for the REDISSE project, WAHO has 4 months starting from the closing date to pay the invoices for goods, works, non-consulting services and consulting services, training and operating costs engaged and delivered under the project before the closing date. Phase 1 started in 2016 covering Guinea, Sierra Leone, and Senegal. Phase 2 begun in 2017 and covered Togo, Guinea-Bissau, Nigeria and Liberia. Phase 3 preparations commenced in late 2017 and currently covers Benin, Burkina Faso, Mali, Niger, and Mauritania. ECOWAS member countries expected to join before the end of the project include Cape Verde, Ghana, Côte d'Ivoire, and The Gambia. Contributions to the Project • US$ 400M - World Bank (IDA) • US$ 341M - MDTF Canada • US$ 2M - China • US$ 8.9M - DSWRA TF Under the project, WAHO has a budget allocation of US$20 million from the IDA funds and US$8.9 million from the Disease Surveillance and Response in West Africa Multi-Donor (DSWRA) Trust Fund. Objectives of the Project • To strengthen national and regional cross-sectoral capacity for collaborative disease surveillance and epidemic preparedness in West Africa; and • In the event of an eligible crisis or emergency, to provide immediate and effective response to the said eligible crisis or emergency. Components of the Project • Component 1: Surveillance and health information; • Component 2: Strengthening laboratory capacity building; • Component 3: Emergency Preparedness and Response; • Component 4: Human resource management for effective disease surveillance and outbreak preparedness; and • Component 5: Institutional Capacity Building, Project Management, Coordination and Advocacy. 2 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Year ended 31 December 2023 REPORT OF THE PROJECT MANAGEMENT TEAM The Project Management Team presents herewith the audited financial statements for the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2023. Statement of the Project Management T sibilities The Project Management Team is responsible for the preparation of the financial statements for the period, which have been prepared in all material respects in accordance with the accounting policies described in note 1 to the financial statement. In preparing these financial statements, the Project Management Team has selected suitable accounting policies and then applied them consistently, made judgements that are reasonable and prudent and followed the requirements of the project financing agreement IDA D1310 and additional financing agreement IDA E1330 between World Bank and WAHO . The Project Management Team is responsible for ensuring that the Project keeps proper accounting records that disclose with reasonable accuracy at any time the financial performance of the Project. The Project Management Team is also responsible for safeguarding the assets of the Project and taking reasonable steps for the prevention and detection of fraud and other irregularities. Principal activities of the Project The principal activities under the Project are stated on page 2 of this report. Financial Results The Statement of Resources and Uses of funds on page 7 shows net increase in project funds during the year. Independent Auditor PwC has expressed willingness to continue in office as auditors for the project in accordance with the agreed contract dated 26 August 2021. BY ORDER OF THE PROJECT MANAGEMENT TEAM .. Director General Director of Administration and Finance Date: 18 / 06 / 2024 Date 18/06/2024 3 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS Our opinion In our opinion, the accompanying financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) (the Project) for the year ended 31 December 2023 are prepared, in all material respects, in accordance with the financial reporting provisions of the project financing agreement IDA D1310 and additional financing agreement IDA E1330 between West African Health Organisation (WAHO) and World Bank. What we have audited We have audited the financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2023. The financial statements comprise: • the statement of resources and uses of funds for the year ended 31 December 2023; • the statement of assets and liabilities as at 31 December 2023; and • the notes to the financial statements, which include a summary of material accounting policy information and other explanatory information. Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the REDISSE project, the West African Health Organization (WAHO) and the World Bank in accordance with the International Code of Ethics for Professional Accountants (including International Independence Standards) (the Code) issued by the International Ethics Standards Board for Accountants. We have fulfilled our other ethical responsibilities in accordance with the Code. Emphasis of matter – Basis of accounting and restriction on distribution and use We draw attention to note 1 to the financial statements, which describes the basis of accounting. The financial statements are prepared in accordance with the financial reporting provisions of the Project Financing Agreement IDA D1310 and additional financing agreement IDA E1330. As a result, the financial statements may not be suitable for another purpose. Our report is intended solely for the West African Health Organisation and the World Bank and should not be distributed to or used by parties other than the West African Health Organisation and World Bank. Our opinion is not modified in respect of this matter. 4 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Other Information The Project Management Team is responsible for the other information. The other information comprises the General Information and the Report of the Project Management Team but does not include the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information identified above and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Responsibilities of management and those charged with governance for the financial statements Management is responsible for the preparation of the financial statements in accordance with the financial reporting provisions of the Project Financing Agreement IDA 1310 and additional financing agreement IDA E1330, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, management is responsible for assessing the Project’s ability to continue as a going concern. Under the terms of the financing agreement the project will end on 31 August 2023. Those charged with governance are responsible for overseeing the Project’s financial reporting process. Auditor’s responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also: 5 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Auditor’s responsibilities for the audit of the financial statements (continued) • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Project’s internal control; • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management; and • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Project’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Project’s to cease to continue as a going concern. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. The engagement partner on the audit resulting in this independent auditor’s report is Maxwell Darkwa ((ICAG/P/1143). PricewaterhouseCoopers (ICAG/F/2024/028) Chartered Accountants Accra, Ghana 20 June 2024 6 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 STATEMENT OF RESOURCES AND USES OF FUNDS (All amounts are expressed in US dollars unless otherwise stated) Notes Year ended 31 Cumulative to Cumulative to December 2023 date 2022 RESOURCES US$ US$ US$ Balance as at 1 January 2023 109,325 - - Receipts from the World Bank 2 482,178 15,851,961 15,369,783 Disbursement to 3rd parties by the World Bank on behalf of REDISSE 3 1,639,411 15,034,930 13,395,519 Reimbursement WAHO Prefinances 4 1,186,871 1,309,540 122,669 Reimbursement from partners 5 82,839 82,839 - 3,500,624 32,279,270 28,887,971 USES Expenses per project components 6 2,256,335 30,042,445 27,786,110 Disbursements to implementing partners 7 - 867,885 867,885 Foreign exchange losses 8 - 1,982 1,982 Expenses prefinanced by WAHO 9 1,588,969 1,711,638 122,669 Total Uses of Funds 3,845,304 32,623,950 28,778,646 Net increase in project funds during the year (344,680) (344,680) 109,325 The notes on pages 9 to13 are an integral part of these financial statements. The financial statements on pages 7 to13 were approved by the Project Management 18/06/2024 and signed on its behalf by: Team on ....................... Director General Director of Administration and Finance 7 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 STATEMENT OF ASSETS AND LIABILITIES (All amounts are expressed in US dollars unless otherwise stated) As at 31 December 2023 2022 Note Current assets Cash and cash equivalents 10 57,418 273,606 Total current assets 57,418 273,606 Current liabilities Accounts payable 11 402,098 164,281 Total current liabilities 402,098 164,281 Net assets (344,680) 109,325 Represented by: Accumulated fund 12 (344,680) 109,325 The notes on pages 9 to13 are an integral part of these financial statements. 8 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 NOTES (All amounts in the notes are expressed in US dollars unless otherwise stated) 1. Accounting policies The following are the material accounting policies adopted in the preparation of these financial statements: (a) Basis of accounting The financial statements have been prepared in accordance with the requirements of the project financing agreement IDA D1310 and additional financing agreement IDA E1330 between World Bank and WAHO. (b) Resources Receipts from the World Bank These are recognised as resources upon receipt of funds in the Project’s designated bank account. Disbursement to 3rd parties by the World Bank on behalf of REDISSE These are direct payments made to implementing partners by World Bank for project activities. Reimbursements – WAHO Prefinances These are reimbursements made by the World Bank, to WAHO’s general fund accounts for project activities prefinanced by WAHO. Reimbursement from partners These are reimbursements made by implementing partners, to WAHO’s general fund accounts for unspent direct payments made by World Bank for project activities. (c) Uses This comprises expenditure incurred under the five (5) components of the project. Uses of funds are recognised when payment is made for goods and services relating to project activities. (d) Fixed assets Fixed assets are expensed in the year of acquisition. (e) Foreign currency translation Transactions in foreign currencies (currencies other than the United States Dollar) are converted at the rate ruling at the date of the transaction. Current assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the balance sheet date. Gains or losses arising on foreign currency transactions are credited to or charged against recurrent expenditure in the period in which they arise. 9 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 NOTES (CONTINUED) (All amounts are expressed in US dollars unless otherwise stated) 1. Accounting policies (continued) (f) Accounts payable This relates to amounts due to WAHO for prefinancing REDISSE project activities. (g) Commitments These are project expenses incurred and yet to be paid. 2. Receipts from the World Bank Year ended 31 December 2023 Funds received – 31st tranche 482,178 3. Disbursement to 3rd parties by the World Bank on behalf of REDISSE Year ended 31 December 2023 Disbursement to Centre for International Cooperation in 456,442 Health and Development (CCISD) Disbursement to Foundation Merieux 936,068 Disbursement to CEDES Afrique 246,901 1,639,411 4. Reimbursement – WAHO Prefinances These are reimbursements to WAHO by World Bank for prefinancing the REDISSE project activities. 5. Reimbursement from partners These are reimbursements to WAHO by implementing partners for unspent project funds. 10 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 NOTES (CONTINUED) (All amounts are expressed in US dollars unless otherwise stated) Year ended 31 Cumulative to Cumulative December 2023 date to 2022 6. Expenses per project components Component 1: Surveillance and health information; 1,717,557 15,307,741 13,590,184 Component 2: Laboratory capacity building 47,749 860,491 812,742 Component 3: Emergency Preparedness and Response 49,707 6,067,631 6,017,924 Component 5: Institutional capacity strengthening, Project management, coordination and advocacy 441,322 7,806,582 7,365,260 2,256,335 30,042,445 27,786,110 7. Disbursements to implementing partners Disbursements to implementing partners - 867,885 867,885 8. Foreign exchange losses Losses on foreign exchange - 1,982 1,982 9. Expenses prefinanced by WAHO Prefinance from WAHO 1,588,969 1,642,069 53,100 Prefinance from P/MTN - 19,693 19,693 Prefinance from MRH - 42,016 42,016 Prefinance from SWEDD - 7,860 7,860 1,588,969 1,711,638 122,669 11 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 NOTES (CONTINUED) (All amounts in the notes are expressed in US dollars unless otherwise stated) 10. Cash and cash equivalents Year ended 31 Year ended 31 December December 2023 2022 Cash at bank 57,418 273,606 11. Accounts payable 2023 2022 Prefinance from WAHO 402,098 164,281 Accounts payable represents pre-financed project expenditure by WAHO on behalf of the REDISSE Project and yet to be reimbursed as at 31 December 2023. 12. Accumulated fund 2023 2022 Cash balance as at 31 December 57,418 273,606 Less: Prefinances from WAHO (402,098) (164,281) Fund balance (344,680) 109,325 13. Commitments Consultancy fees 29,420 14,198 This represents outstanding payment to consultants and bank charges for the year ended 31 December 2023. 14. Events after reporting date As of 31 December 2023, there was total expenditure of USD 402,098 represented as an account payable as a result of project expenses prefinanced by WAHO’s general funds. Subsequently, payment was made directly to WAHO dated 16 January 2024. Committed expenses of USD 29,420 (Note 13) will be settled with the available cash balance of USD 57,418 as at year end. 12 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 NOTES (CONTINUED) (All amounts in the notes are expressed in US dollars unless otherwise stated) 14. Events after reporting date (continued) As at 31 December 2023 Accounts payable (402,098) Financed By; Direct transfer from World Bank 402,098 - Cash balance 57,418 Commitments to be paid (Note 13) (29,420) Fund balance* 27,998 * This amount of USD 27,998 is to be refunded to the World Bank. 13 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE DESIGNATED ACCOUNTS STATEMENTS Our opinion In our opinion, the accompanying financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) (the Project) for the year ended 31 December 2023 are prepared, in all material respects, in accordance with the financial reporting provisions of IDA D1310 and additional financing agreement IDA E1330 of the Project financing agreement between West African Health Organisation (WAHO) and World Bank. What we have audited We have audited the financial statements of the Regional Disease Surveillance Systems Enhancement in West Africa Project (REDISSE) for the year ended 31 December 2023. The financial statements comprise: • designated account statement for the year 31 December 2023; and • the notes to the financial statements, which include a summary of material accounting policy information and other explanatory information. Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the REDISSE project, the West African Health Organization (WAHO) and the World Bank in accordance with the International Code of Ethics for Professional Accountants (including International Independence Standards) (the Code) issued by the International Ethics Standards Board for Accountants. We have fulfilled our other ethical responsibilities in accordance with the Code. Emphasis of matter – Basis of accounting and restriction on distribution and use We draw attention to note 1 to the financial statements, which describes the basis of accounting. The financial statements are prepared in accordance with the financial reporting provisions of the IDA D1310 and additional financing agreement IDA E1330 of the Project Financing Agreement. As a result, the financial statements may not be suitable for another purpose. Our report is intended solely for the West African Health Organisation and the World Bank and should not be distributed to or used by parties other than the West African Health Organisation and World Bank. Our opinion is not modified in respect of this matter. 14 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Other Information The Project Management Team is responsible for the other information. The other information comprises the General Information and the Report of the Project Management Team but does not include the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information identified above and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Responsibilities of management and those charged with governance for the financial statements Management is responsible for the preparation of the financial statements in accordance with the financial reporting provisions of IDA 1310 of the Project’s Financing Agreement and additional financing agreement IDA E1330, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, management is responsible for assessing the Project’s ability to continue as a going concern. Under the terms of the financing agreement the project will end on 31 August 2023. Those charged with governance are responsible for overseeing the Project’s financial reporting process. Auditor’s responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also: 15 INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF PROJECT MANAGEMENT TEAM, WEST AFRICAN HEALTH ORGANISATION REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS (CONTINUED) Auditor’s responsibilities for the audit of the financial statements (continued) • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Project’s internal control; • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management; and • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Project’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Project’s to cease to continue as a going concern. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. The engagement partner on the audit resulting in this independent auditor’s report is Maxwell Darkwa ((ICAG/P/1143). PricewaterhouseCoopers (ICAG/F/2024/028) Chartered Accountants Accra, Ghana 20 June 2024 16 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) in West Africa Project Financial Statements For the year ended 31 December 2023 DESIGNATED ACCOUNT STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 (All amounts are expressed in US dollars unless otherwise stated) 2023 OOAS PROJET REDISSE/ Financing Agreements IDA D1310 and IDA E1330 170040359017 US$ Balance as at 1 January 2023 109,325 Receipts from World Bank 482,178 Disbursement to 3rd parties by the World Bank on behalf of REDISSE 1,639,411 Reimbursement WAHO Prefinances 1,186,871 Reimbursement from partners 82,839 Total funds available in the designated accounts 3,500,624 Movement: Eligible expenses paid during the year (3,845,304) Total payments (3,845,304) Balance at 31 December 2023 (344,680) Add: Prefinance from WAHO 402,098 Actual cash/bank balance as at 31 December 2023 57,418 The notes on page 18 are an integral part of these financial statements. The Designated Account statement on pages 17 and 18 were approved by the Project Management Team on 18 June 2024 and signed on its behalf by: Director General Director of Administration and Finance 17 West African Health Organization (WAHO) The Regional Disease Surveillance Systems Enhancement (REDISSE) In West Africa Project Financial Statements For the year ended 31 December 2023 NOTES 1. Accounting policies The following are the material accounting policies adopted in the preparation of the designated account statement: (a) Basis of accounting The Designated Account Statement has been prepared in accordance with the provisions of the financing agreement IDA D1310 and additional financing agreement IDA E1330. (b) Opening balance This amount represents prior year closing balances brought forward. (c) Receipts from World Bank This represents transfers from the World Bank. Transfers are recognised as income when it hits the designated accounts. (d) Disbursement to 3rd parties by the World Bank on behalf of REDISSE These are direct payments made to implementing partners by World Bank for project activities. (e) Reimbursements – WAHO Prefinances These are reimbursements made by the World Bank, to WAHO’s general fund accounts for project activities prefinanced by WAHO. (f) Reimbursement from partners These are reimbursements made by implementing partners, to WAHO’s general fund accounts for unspent direct payments made by World Bank for project activities. (g) Eligible expenditure This is made up all eligible payments made by the project during the period under review. 18 Annex 1 – RECONCILIATION OF AMOUNT RECEIVED BY REDISSE AND AMOUNT DISBURSED BY WORLD BANK Disbursement Amount Received by Amount disbursed by method Receiving Agency Date REDISSE World Bank Difference USD USD Transfers from World Bank to REDISSE designated account 34 WAHO REDISSE 17-April-23 482,178 482,178 - Total 482,178 482,178 - 'SM 02 22-Dec-23 244,469 244,469 - Direct payment to 'DPD SM 01 BIS 10-Jul-23 211,973 211,973 - implementing 'PD FMX 001 7-Jul-23 379,379 379,379 - partners 'FM 03 22-Dec-23 556,689 556,689 CEDES 02 BIS 22-Dec-23 246,901 246,901 Total 1,639,411 1,639,411 - Reimbursement – 'OOAS 01 BIS 13-Jul-23 453,137 453,137 - WAHO Prefinances 'REMB OOAS 2 19-Jul-23 733,734 733,734 - Total 1,186,871 1,186,871 - Reimbursement from partners N01INFT231520507 01-Jun-23 82,839 82,839 - Total 82,839 82,839 Total disbursements 3,391,299 3,391,299 - Annex 2 – Schedule of Fixed Assets Register SUMMARY OF ADDITIONS TO FIXED ASSETS FOR THE YEAR ENDED 31 DECEMBER 2023 ASSETS Purchase date Location Amount (XOF) Motor Vehicle Toyota Land Cruiser PRADO 4*4 - Station wagon - BVA 01/05/2018 WAHO 30,500,000 Landcruiser Prado TX-L 4x4 2986 CC DSL 5P- (BY 6710 MD) 03/09/2018 WAHO 27,589,177 TOTAL 58,089,177 IT Equipment Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZN 2023-08-25 Procurement Specialist 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154LZT 2023-08-25 Financial Management Specialist 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154LZ7 2023-08-25 Projects Accountant 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZK 2023-08-25 SWEDD Project Coordinator 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154LZ4 2023-08-25 WAHO Legal Officer 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZX 2023-08-25 Travel & Protocol Officer 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154LZQ 2023-08-25 ICT Consultant/Microsoft 365 Specialist 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154MOP 2023-08-25 Monitoring and Evaluation Specialist 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10)- 5CG3154M0G 2023-08-25 Unité TIC(Pour les réunions) 2,884,418 Annex 2 – Schedule of Fixed Assets Register (Continued) SUMMARY OF ADDITIONS TO FIXED ASSETS FOR THE YEAR ENDED 31 DECEMBER 2023 (CONTINUED) ASSETS Purchase date Location Amount (XOF) IT Equipment Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154M14 2023-08-25 Magasin Central TIC 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154M05 2023-08-25 Magasin Central TIC 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154M0J 2023-08-25 Magasin Central TIC 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZF 2023-08-25 Magasin Central TIC 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZD 2023-08-25 Magasin Central TIC 2,884,418 Hp Laptop (EliteBook 840 14 Inch G10) - 5CG3154LZH 2023-08-25 Magasin Central TIC 2,884,418 TOTAL 43,266,270